# FDA Inspection 816470 - Bloodworks - January 30, 2013

Source: https://www.keypedia.com/records/fda_inspections/bloodworks/5424fc35-fcdd-4dad-9b1c-a94900a3f7b6
Source feed: FDA_Inspections

> FDA Inspection 816470 for Bloodworks on January 30, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 816470
- Company Name: Bloodworks
- Inspection Date: 2013-01-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1312306 - 2026-04-08](https://www.keypedia.com/records/fda_inspections/bloodworks/60037618-9b30-412e-98f1-bb3fc7d93558)
- [FDA Inspection 1190669 - 2022-11-09](https://www.keypedia.com/records/fda_inspections/bloodworks/b2afbcce-8b61-4fdd-9201-4e0e1842ec37)
- [FDA Inspection 1190669 - 2022-11-09](https://www.keypedia.com/records/fda_inspections/bloodworks/9017cfff-2068-4afd-9e90-7cf6ff048341)
- [FDA Inspection 1097659 - 2019-07-18](https://www.keypedia.com/records/fda_inspections/bloodworks/08b8b8db-4212-4a65-b7c9-e6c460791fbd)
- [FDA Inspection 983200 - 2016-08-26](https://www.keypedia.com/records/fda_inspections/bloodworks/35d86c89-3ec3-4120-b6b1-94bead0eac1d)

Company: https://www.keypedia.com/companies/bloodworks/3b106ca6-9872-469d-8a0c-33fc636dc74b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d